Global Drug Safety Solutions and Pharmacovigilance Market Trend and Development Strategy Analysis 2023-2029
Market Analysis and Insights: Global Drug Safety Solutions and Pharmacovigilance Market
The global Drug Safety Solutions and Pharmacovigilance market size in 2022 is 7800.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 7.50% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Drug Safety Solutions and Pharmacovigilance market include PPD Inc (U.S.), Drug Safety Solutions Limited (U.S.), C3i (U.S.), Worldwide Clinical Trials (U.S.), and Bioclinica (U.S.). The share of the top 3 players in the Drug Safety Solutions and Pharmacovigilance market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Drug Safety Solutions and Pharmacovigilance market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Standard Form accounted for XX% of Drug Safety Solutions and Pharmacovigilance market in 2022. Customized Form share of XX%.
Biotechnology and Pharmaceuticals accounted for XX% of the Drug Safety Solutions and Pharmacovigilance market in 2022. Contract Research Organizations (CROS) accounts for XX%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Safety Solutions and Pharmacovigilance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Safety Solutions and Pharmacovigilance market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Safety Solutions and Pharmacovigilance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Safety Solutions and Pharmacovigilance market.
Global Drug Safety Solutions and Pharmacovigilance Scope and Market Size
Drug Safety Solutions and Pharmacovigilance market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Safety Solutions and Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource.
The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Drug Safety Solutions and Pharmacovigilance industry is considered in the report, covering the dynamic analysis of the development of the Drug Safety Solutions and Pharmacovigilance industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
PPD Inc (U.S.)
Drug Safety Solutions Limited (U.S.)
C3i (U.S.)
Worldwide Clinical Trials (U.S.)
Bioclinica (U.S.)
United Biosource LLC (U.S.)
Ennov (Hong Kong)
AB Cube S.A.S. (France)
Labcorp Drug Development (U.S.)
Accenture (Ireland)
ICON plc (U.S.)
Ergomed plc (U.K.)
IQVIA (U.S.)
Genpact (U.S.)
Cognizant (U.S.)
Parexel International Corporation (U.S.)
ArisGlobal (U.S.)
Types list
Standard Form
Customized Form
Application list
Biotechnology and Pharmaceuticals
Contract Research Organizations (CROS)
Hospitals
KPOs/BPOs
Healthcare Providers
Table of Content
1 Drug Safety Solutions and Pharmacovigilance Market Introduction and Overview
1.1 Drug Safety Solutions and Pharmacovigilance Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Drug Safety Solutions and Pharmacovigilance Industry Dynamic Analysis
1.5.1 Drug Safety Solutions and Pharmacovigilance Market Trends Analysis
1.5.2 Drug Safety Solutions and Pharmacovigilance Market Drivers Analysis
1.5.3 Drug Safety Solutions and Pharmacovigilance Market Challenges Analysis
1.5.4 Drug Safety Solutions and Pharmacovigilance Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Drug Safety Solutions and Pharmacovigilance Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Drug Safety Solutions and Pharmacovigilance Revenue and Share by Type
3 Global Drug Safety Solutions and Pharmacovigilance Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Drug Safety Solutions and Pharmacovigilance Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
4.2 Drug Safety Solutions and Pharmacovigilance Growth Insights by Regions
4.2.1 Drug Safety Solutions and Pharmacovigilance Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Drug Safety Solutions and Pharmacovigilance Revenue Market Size by Regions (2018-2023)
4.2.3 North America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
4.2.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
4.2.5 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
4.2.6 Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
4.2.7 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
5 North America
5.1 North America Drug Safety Solutions and Pharmacovigilance Revenue by Countries
5.1.1 North America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Countries
6.1.1 Asia Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Countries
7.1.1 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Drug Safety Solutions and Pharmacovigilance Revenue by Countries
8.1.1 Latin America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Countries
9.1.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Drug Safety Solutions and Pharmacovigilance Market Competition, by Players
10.1 Global Drug Safety Solutions and Pharmacovigilance Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Drug Safety Solutions and Pharmacovigilance Players Market Share in 2022
10.2.2 Top 6 Drug Safety Solutions and Pharmacovigilance Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Drug Safety Solutions and Pharmacovigilance Players Head Office, Business Provided
10.4 Drug Safety Solutions and Pharmacovigilance Mergers & Acquisitions
10.5 Drug Safety Solutions and Pharmacovigilance New Entrants and Expansion Plans
11 Players Profiles
11.1 PPD Inc (U.S.)
11.1.1 PPD Inc (U.S.) Company Profile
11.1.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.1.3 PPD Inc (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.1.4 PPD Inc (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Drug Safety Solutions Limited (U.S.)
11.2.1 Drug Safety Solutions Limited (U.S.) Company Profile
11.2.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.2.3 Drug Safety Solutions Limited (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.2.4 Drug Safety Solutions Limited (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 C3i (U.S.)
11.3.1 C3i (U.S.) Company Profile
11.3.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.3.3 C3i (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.3.4 C3i (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Worldwide Clinical Trials (U.S.)
11.4.1 Worldwide Clinical Trials (U.S.) Company Profile
11.4.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.4.3 Worldwide Clinical Trials (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.4.4 Worldwide Clinical Trials (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bioclinica (U.S.)
11.5.1 Bioclinica (U.S.) Company Profile
11.5.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.5.3 Bioclinica (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.5.4 Bioclinica (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 United Biosource LLC (U.S.)
11.6.1 United Biosource LLC (U.S.) Company Profile
11.6.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.6.3 United Biosource LLC (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.6.4 United Biosource LLC (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Ennov (Hong Kong)
11.7.1 Ennov (Hong Kong) Company Profile
11.7.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.7.3 Ennov (Hong Kong) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.7.4 Ennov (Hong Kong) Business Overview
11.7.5 Recent Developments and Plans
11.8 AB Cube S.A.S. (France)
11.8.1 AB Cube S.A.S. (France) Company Profile
11.8.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.8.3 AB Cube S.A.S. (France) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.8.4 AB Cube S.A.S. (France) Business Overview
11.8.5 Recent Developments and Plans
11.9 Labcorp Drug Development (U.S.)
11.9.1 Labcorp Drug Development (U.S.) Company Profile
11.9.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.9.3 Labcorp Drug Development (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.9.4 Labcorp Drug Development (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Accenture (Ireland)
11.10.1 Accenture (Ireland) Company Profile
11.10.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.10.3 Accenture (Ireland) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.10.4 Accenture (Ireland) Business Overview
11.10.5 Recent Developments and Plans
11.11 ICON plc (U.S.)
11.11.1 ICON plc (U.S.) Company Profile
11.11.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.11.3 ICON plc (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.11.4 ICON plc (U.S.) Business Overview
11.11.5 Recent Developments and Plans
11.12 Ergomed plc (U.K.)
11.12.1 Ergomed plc (U.K.) Company Profile
11.12.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.12.3 Ergomed plc (U.K.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.12.4 Ergomed plc (U.K.) Business Overview
11.12.5 Recent Developments and Plans
11.13 IQVIA (U.S.)
11.13.1 IQVIA (U.S.) Company Profile
11.13.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.13.3 IQVIA (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.13.4 IQVIA (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 Genpact (U.S.)
11.14.1 Genpact (U.S.) Company Profile
11.14.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.14.3 Genpact (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.14.4 Genpact (U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 Cognizant (U.S.)
11.15.1 Cognizant (U.S.) Company Profile
11.15.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.15.3 Cognizant (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.15.4 Cognizant (U.S.) Business Overview
11.15.5 Recent Developments and Plans
11.16 Parexel International Corporation (U.S.)
11.16.1 Parexel International Corporation (U.S.) Company Profile
11.16.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.16.3 Parexel International Corporation (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.16.4 Parexel International Corporation (U.S.) Business Overview
11.16.5 Recent Developments and Plans
11.17 ArisGlobal (U.S.)
11.17.1 ArisGlobal (U.S.) Company Profile
11.17.2 Drug Safety Solutions and Pharmacovigilance Product Overview
11.17.3 ArisGlobal (U.S.) Drug Safety Solutions and Pharmacovigilance Market Performance (2018-2023)
11.17.4 ArisGlobal (U.S.) Business Overview
11.17.5 Recent Developments and Plans
12 Global Drug Safety Solutions and Pharmacovigilance Forecast Market Insights by Type
12.1 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast by Type (2023-2029)
13 Global Drug Safety Solutions and Pharmacovigilance Forecast Market Insights by Application
13.1 Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Drug Safety Solutions and Pharmacovigilance Forecast Market Size (2023-2029)
14.2 Drug Safety Solutions and Pharmacovigilance Growth Forecast Insights by Regions
14.2.1 Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Drug Safety Solutions and Pharmacovigilance Forecast Market Size (2023-2029)
14.2.3 Europe Drug Safety Solutions and Pharmacovigilance Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Forecast Market Size (2023-2029)
14.2.5 Latin America Drug Safety Solutions and Pharmacovigilance Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer
List of Tables and Figures
Figure Drug Safety Solutions and Pharmacovigilance Picture
Table Product Definition of Drug Safety Solutions and Pharmacovigilance
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018 VS 2023 VS 2029)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue by Type (2018-2023)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue and Share by Type (2018-2023)
Table Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018 VS 2023 VS 2029)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue by Application (2018-2023)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2018-2023)
Figure Global Drug Safety Solutions and Pharmacovigilance Revenue Market Size Growth (2018-2023)
Table Drug Safety Solutions and Pharmacovigilance Market Size by Regions: 2018 VS 2023 VS 2029
Table Drug Safety Solutions and Pharmacovigilance Revenue Market Size by Regions (2018-2023)
Table Drug Safety Solutions and Pharmacovigilance Revenue and Share by Regions (2018-2023)
Figure North America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
Figure Europe Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
Figure Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
Figure Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
Figure Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2018-2023)
Table North America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
Table North America Drug Safety Solutions and Pharmacovigilance Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Canada Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Canada Drug Safety Solutions and Pharmacovigilance Sales and Growth (2018-2023)
Table Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
Table Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Japan Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Korea Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Southeast Asia Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure India Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Australia Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Table Europe Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
Table Europe Drug Safety Solutions and Pharmacovigilance Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure France Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure UK Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Italy Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Russia Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Spain Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Nordic Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Table Latin America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
Table Latin America Drug Safety Solutions and Pharmacovigilance Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Argentina Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Mexico Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Table Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2018-2023)
Table Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure South Africa Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure UAE Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Turkey Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Figure Saudi Arabia Drug Safety Solutions and Pharmacovigilance Revenue and Growth (2018-2023)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2018-2023)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Drug Safety Solutions and Pharmacovigilance Players Market Concentration Ratio (CR5) (2018-2023)
Table Drug Safety Solutions and Pharmacovigilance Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table PPD Inc (U.S.) Profile
Table Product Overview
Table PPD Inc (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure PPD Inc (U.S.) Revenue and Growth Rate
Figure PPD Inc (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Drug Safety Solutions Limited (U.S.) Profile
Table Product Overview
Table Drug Safety Solutions Limited (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Drug Safety Solutions Limited (U.S.) Revenue and Growth Rate
Figure Drug Safety Solutions Limited (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table C3i (U.S.) Profile
Table Product Overview
Table C3i (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure C3i (U.S.) Revenue and Growth Rate
Figure C3i (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Worldwide Clinical Trials (U.S.) Profile
Table Product Overview
Table Worldwide Clinical Trials (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Worldwide Clinical Trials (U.S.) Revenue and Growth Rate
Figure Worldwide Clinical Trials (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bioclinica (U.S.) Profile
Table Product Overview
Table Bioclinica (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Bioclinica (U.S.) Revenue and Growth Rate
Figure Bioclinica (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table United Biosource LLC (U.S.) Profile
Table Product Overview
Table United Biosource LLC (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure United Biosource LLC (U.S.) Revenue and Growth Rate
Figure United Biosource LLC (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Ennov (Hong Kong) Profile
Table Product Overview
Table Ennov (Hong Kong) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Ennov (Hong Kong) Revenue and Growth Rate
Figure Ennov (Hong Kong) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table AB Cube S.A.S. (France) Profile
Table Product Overview
Table AB Cube S.A.S. (France) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure AB Cube S.A.S. (France) Revenue and Growth Rate
Figure AB Cube S.A.S. (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Labcorp Drug Development (U.S.) Profile
Table Product Overview
Table Labcorp Drug Development (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Labcorp Drug Development (U.S.) Revenue and Growth Rate
Figure Labcorp Drug Development (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Accenture (Ireland) Profile
Table Product Overview
Table Accenture (Ireland) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Accenture (Ireland) Revenue and Growth Rate
Figure Accenture (Ireland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table ICON plc (U.S.) Profile
Table Product Overview
Table ICON plc (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure ICON plc (U.S.) Revenue and Growth Rate
Figure ICON plc (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Ergomed plc (U.K.) Profile
Table Product Overview
Table Ergomed plc (U.K.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Ergomed plc (U.K.) Revenue and Growth Rate
Figure Ergomed plc (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table IQVIA (U.S.) Profile
Table Product Overview
Table IQVIA (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure IQVIA (U.S.) Revenue and Growth Rate
Figure IQVIA (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Genpact (U.S.) Profile
Table Product Overview
Table Genpact (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Genpact (U.S.) Revenue and Growth Rate
Figure Genpact (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Cognizant (U.S.) Profile
Table Product Overview
Table Cognizant (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Cognizant (U.S.) Revenue and Growth Rate
Figure Cognizant (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Parexel International Corporation (U.S.) Profile
Table Product Overview
Table Parexel International Corporation (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure Parexel International Corporation (U.S.) Revenue and Growth Rate
Figure Parexel International Corporation (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table ArisGlobal (U.S.) Profile
Table Product Overview
Table ArisGlobal (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross and Gross Margin (2018-2023)
Figure ArisGlobal (U.S.) Revenue and Growth Rate
Figure ArisGlobal (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Drug Safety Solutions and Pharmacovigilance Revenue Forecast by Type (2023-2029)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue and Share Forecast by Type (2023-2029)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue by Application (2023-2029)
Table Global Drug Safety Solutions and Pharmacovigilance Revenue and Share by Application (2023-2029)
Figure Global Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size (2023-2029)
Table Drug Safety Solutions and Pharmacovigilance Revenue Forecast by Regions (2023-2029)
Table Drug Safety Solutions and Pharmacovigilance Revenue and Share Forecast by Regions (2023-2029)
Figure North America Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size (2023-2029)
Figure Europe Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size (2023-2029)
Figure Latin America Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|